Study to Evaluate Markers of Response in Locally Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: OTHER: Bevacizumab, docetaxel and doxorubicin followed by surgery
Sponsor: Clinica Universidad de Navarra, Universidad de Navarra
Collaborators: Roche Farma, S.A